Compare CPAY & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPAY | ICUCW |
|---|---|---|
| Founded | 1986 | N/A |
| Country | United States | United States |
| Employees | N/A | 18 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.7B | N/A |
| IPO Year | 2010 | 2021 |
| Metric | CPAY | ICUCW |
|---|---|---|
| Price | $309.97 | $0.01 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $369.64 | N/A |
| AVG Volume (30 Days) | ★ 527.9K | N/A |
| Earning Date | 02-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.04 | N/A |
| EPS | ★ 14.72 | N/A |
| Revenue | ★ $4,314,608,000.00 | N/A |
| Revenue This Year | $15.86 | N/A |
| Revenue Next Year | $15.55 | N/A |
| P/E Ratio | $21.07 | ★ N/A |
| Revenue Growth | ★ 11.27 | N/A |
| 52 Week Low | $252.84 | N/A |
| 52 Week High | $400.81 | N/A |
| Indicator | CPAY | ICUCW |
|---|---|---|
| Relative Strength Index (RSI) | 57.54 | 39.98 |
| Support Level | $301.00 | $0.01 |
| Resistance Level | $316.01 | $0.01 |
| Average True Range (ATR) | 7.54 | 0.00 |
| MACD | -0.60 | 0.00 |
| Stochastic Oscillator | 50.92 | 49.09 |
Corpay Inc is a corporate payments company that helps businesses and consumers manage and pay their expenses. Its suite of modern payment solutions helps customers manage vehicle-related expenses, lodging expenses, and corporate payments. Its reportable segments are; Vehicle Payments, Corporate Payments, Lodging Payments, and Other. The group's geographic areas are the United States, Brazil, the United Kingdom, and Other.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.